BRK.B vs RARE · rev $371.44B vs rev $350.0M
BRK.B (BRK.B) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
BRK.B currently screens at market cap $0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the BRK.B and RARE stock pages for the full models.
Not investment advice.